Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 83.94 |
| Open | 84.01 |
| Bid | 83.05 x 900 |
| Ask | 83.99 x 1100 |
| Day's Range | 82.70 - 84.65 |
| 52 Week Range | 57.17 - 89.74 |
| Volume | |
| Avg. Volume | 7,297,748 |
| Market Cap | 105.356B |
| Beta (5Y Monthly) | 0.43 |
| PE Ratio (TTM) | 31.82 |
| EPS (TTM) | 2.64 |
| Earnings Date | Feb 02, 2023 |
| Forward Dividend & Yield | 2.92 (3.50%) |
| Ex-Dividend Date | Dec 14, 2022 |
| 1y Target Est | 86.92 |
- Zacks
Drug/Biotech Stocks Q4 Earnings Due on Feb 2: GILD, MRK & Others
Let's look at the four biotech/pharma companies slated to release quarterly results on Feb 2.
- Zacks
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
- Business Wire
Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast Cancer
FOSTER CITY, Calif., February 01, 2023--Gilead awards $7.6 million in grants to 24 U.S.-based organizations through the newly created Toward Health Equity Oncology Grant(TM).
© 2023 Yahoo. All rights reserved.
